These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17922749)

  • 1. Effect of intravenous iron on insulin sensitivity in dialysis patients.
    Iliescu EA; White CA; Toffelmire EB; Hudson RW
    Hemodial Int; 2007 Oct; 11(4):492-3. PubMed ID: 17922749
    [No Abstract]   [Full Text] [Related]  

  • 2. Iron utilization after iron dextran administration for iron deficiency in patients with dialysis-associated anemia: a prospective analysis and comparison of two agents.
    Roe DJ; Harford AM; Zager PG; Wiltbank TB; Kirlin L; Della Valle AM; Van Wyck DB
    Am J Kidney Dis; 1996 Dec; 28(6):855-60. PubMed ID: 8957037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic equivalence of oral and intravenous iron in renal dialysis patients.
    Strickland ID; Chaput de Saintonge DM; Boulton FE; Francis B; Roubikova J; Waters JI
    Clin Nephrol; 1977 Feb; 7(2):55-7. PubMed ID: 321170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.
    Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M
    Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe intravascular haemolysis and acute renal failure following intravenous administration of iron dextran.
    Buus NH; Jensen JD
    Nephrol Dial Transplant; 2007 Feb; 22(2):661-2. PubMed ID: 16968716
    [No Abstract]   [Full Text] [Related]  

  • 6. Egg on the table.
    Kazama JJ; Kaneko Y
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):14-5. PubMed ID: 19129315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of iron therapy in patients in long-term haemodialysis (author's transl)].
    Serra A; Morlans M; Olmos A; Camps J; Rodríguez JA; Carreras A; Soriano B; Bartolomé J; Piera L
    Med Clin (Barc); 1982 Apr; 78(8):313-7. PubMed ID: 7087599
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous iron dextran complex (Undiluted).
    Desai AB; Shah AR; Parikh SM; Modi V
    Indian Pediatr; 1972 Dec; 9(12):796-9. PubMed ID: 4661553
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
    Pinsk V; Levy J; Moser A; Yerushalmi B; Kapelushnik J
    Isr Med Assoc J; 2008 May; 10(5):335-8. PubMed ID: 18605353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients.
    Kim JM; Ihm CH; Kim HJ
    Int J Lab Hematol; 2008 Feb; 30(1):46-52. PubMed ID: 18190467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory anemia in a patient with allergy to intravenous iron drugs.
    Fishbane S
    Kidney Int; 2006 May; 69(10):1910-3. PubMed ID: 16625145
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemoglobin response following intramuscular iron dextran (imferon) in children with iron deficiency anaemia.
    Bwibo NO
    East Afr Med J; 1970 May; 47(5):254-7. PubMed ID: 5473596
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice.
    Bhandari S; Naudeer S
    J Eval Clin Pract; 2008 Dec; 14(6):996-1001. PubMed ID: 18785894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
    Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
    J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.
    Auerbach M; Pappadakis JA; Bahrain H; Auerbach SA; Ballard H; Dahl NV
    Am J Hematol; 2011 Oct; 86(10):860-2. PubMed ID: 21922526
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
    Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
    J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
    Usmanov RI; Zueva EB; Silverberg DS; Shaked M
    J Nephrol; 2008; 21(2):236-42. PubMed ID: 18446719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients.
    Hörl WH
    Perit Dial Int; 2001; 21(5):527-8. PubMed ID: 11757843
    [No Abstract]   [Full Text] [Related]  

  • 20. Total dose iron infusion.
    Nath K; Omar JB
    J Assoc Physicians India; 1967 May; 15(5):249-54. PubMed ID: 6074822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.